Patent ID: 8173633

Claim:
A method for treatment of glucose metabolism disorder in a subject having liver cirrhosis or treatment of a neoplastic disease, comprising: administering to a subject in need thereof a benzothiophene alkyl ether compound represented by general formula (I): wherein, R 1 and R 2 may be the same or different and each represents one or more groups selected from the group consisting of a hydrogen atom, a halogen atom, an optionally substituted alkyl, aryl, aralkyl, alkoxy, aryloxy, alkylthio, arylthio, alkenyl, alkenyloxy, amino, alkylsulfonyl, arylsulfonyl, carbamoyl or heterocyclic group, an optionally protected amino, hydroxyl or carboxyl group, a nitro group, and an oxo group; R 3 represents an optionally substituted alkylamino group, or an optionally protected amino or hydroxyl group; and m and n may be the same or different and each represents an integer of 1 to 6, or a pharmaceutically acceptable salt thereof.